C07D 211/34
With hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero
Official title: with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
C07D211/34 (With hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero) appears on 633 US grants and 673 published applications in this corpus.
Search patents in C07D- Granted patents
- 633
- Published applications
- 673
- Assignees
- 416
- Inventors
- 2,504
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 6 | 0 |
| 1984 | 6 | 0 |
| 1985 | 7 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 4 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 5 | 0 |
| 1995 | 10 | 0 |
| 1996 | 4 | 0 |
| 1997 | 17 | 0 |
| 1998 | 15 | 0 |
| 1999 | 14 | 0 |
| 2000 | 20 | 0 |
| 2001 | 15 | 4 |
| 2002 | 27 | 22 |
| 2003 | 21 | 29 |
| 2004 | 11 | 44 |
| 2005 | 22 | 37 |
| 2006 | 17 | 42 |
| 2007 | 20 | 34 |
| 2008 | 21 | 20 |
| 2009 | 20 | 31 |
| 2010 | 13 | 35 |
| 2011 | 15 | 21 |
| 2012 | 14 | 18 |
| 2013 | 20 | 20 |
| 2014 | 18 | 22 |
| 2015 | 16 | 37 |
| 2016 | 29 | 23 |
| 2017 | 30 | 29 |
| 2018 | 18 | 22 |
| 2019 | 23 | 19 |
| 2020 | 13 | 25 |
| 2021 | 20 | 25 |
| 2022 | 14 | 24 |
| 2023 | 18 | 35 |
| 2024 | 10 | 15 |
| 2025 | 10 | 28 |
| 2026 | 8 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of spinster homolog 2 (SPNS2) for use in therapy22 Sep 2026US 12,741,944 B2University of Virginia Patent Foundation
- N-heteroarylalkyl-2-(heterocyclyl and heterocyclylmethyl) acetamide derivatives as SSTR4 agonists22 Sep 2026US 12,741,957 B2Takeda Pharmaceutical Company Limited
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Modular lipid compounds and two- to three-component lipid nanoparticle compositions28 Jul 2026US 12,691,068 B2Sun Vax mRNA Therapeutics Inc.
- Pesticidally active cyclic amine compounds21 Apr 2026US 12,604,895 B2Syngenta Crop Protection AG
- Probenecid compounds for the treatment of inflammasome-mediated lung disease8 Oct 2026US 2026/0308131 A1Bacainn Biotherapeutics, Ltd.
- Diphenoxylate artificial hapten, diphenoxylate artificial antigen, preparation methods therefor, and use thereof1 Oct 2026US 2026/0297030 A1Hangzhou Alltest Biotech Co., Ltd
- Composition for preventing or treating cancer diseases comprising aryl-piperidine derivative20 Aug 2026US 2026/0242336 A1Korea Institute of Radiological & Medical Sciences
- Substituted phenol derivative and use thereof30 Jul 2026US 2026/0217651 A1Chengdu MFS Pharma. Co., Ltd.
- Probenecid compounds for the treatment of inflammasome-mediated dermatological conditions25 Jun 2026US 2026/0176232 A1Bacainn Biotherapeutics, Ltd.
Most cited
By later US patents
- Delivery of multiple doses of medications377US 5,837,284 A1998
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Heterocyclo inhibitors of potassium channel function120US 7,005,436 B2Bristol-Myers Squibb Company · 2006
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Phenidate drug formulations having diminished abuse potential107US 6,355,656 B1Celgene Corporation · 2002